 | Juvenile Idiopathic Arthritis |
| Systemic Lupus Erythematosus Antiphospholipid antibodies, Neonatal lupus |
| Juvenile Dermatomyositis |
| Scleroderma |
| Juvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA) |
| Kawasaki Disease |
| Henoch-Schoenlein Purpura |
| Rare Juvenile Primary Systemic Vasculitis Polyarteritis nodosa, Takayasu, Wegener’s granulomatosis, Other vasculitides |
| Rheumatic Fever And Post-streptococcal Reactive Arthritis |
| Autoinflammatory Diseases Blau, CANDLE, CAPS, CRMO, DIRA, FMF, Majeed, MKD, NALP-12, PAPA, PFAPA,TRAPS |
| Behcet’s Disease |
| Lyme Arthritis |
| Limb Pain Syndromes Fibromyalgia Syndrome, Localized Idiopathic Musculoskeletal Pain Syndrome, Erythromelalgia, Growing pains, Benign Hypermobility Syndrome, Transient Synovitis, Patellofemoral Pain – Knee Pain, Slipped Capital Femoral Epiphysis, Osteochondroses, Legg-Calvé-Perthes Disease, Osgood-Schlatter Disease, Sever's Disease, Freiberg's disease, Scheuermann's disease |
| Drug Therapy NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), Cyclosporine A, Intravenous immunoglobulins, Corticosteroids, Azathioprine, Cyclophosphamide, Methotrexate, Leflunomide, Hydroxychloroquine, Sulfasalazine, Colchicine, Mycophenolate mofetil, Biologic drugs, New drugs under development |
| PRES recommendations in the corona era- COVID-19 |
